Ian Michael Estepan - 09 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Operating Officer
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Issuer symbol
SRPT
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 20:01:03 UTC
Previous filing
03 Mar 2026
Next filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Estepan Ian Michael Chief Operating Officer 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan 11 Mar 2026 0001836254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -1,036 -0.51% $16.95* 203,663 09 Mar 2026 Direct F1
transaction SRPT Common Stock Tax liability -583 -0.29% $16.95* 203,080 09 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
F2 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.